About
75.06USD+1.22 +1.65%
Closed • Updated at 13:37 GMT+00:00Market Cap$12.40B
Volume2.01M
Beta0.74
RSI50.38
Gross Margin96.73%
Ionis Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 4 2026
Ionis to host 2026 virtual Annual Meeting of Stockholders
Apr 29 2026
Ionis reports first quarter 2026 financial results and highlights progress on key programs
Apr 28 2026
Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
Apr 21 2026
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
Apr 15 2026
Ionis to hold first quarter 2026 financial results webcast
Google Übersetzer